FDA Advisory Committee Recommends Against Antiplatelet Therapy Cangrelor

[Marketwired] – The Medicines Company announced today that the U.S. Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee has voted to recommend against approval of the intravenous antiplatelet … more

View todays social media effects on MDCO

View the latest stocks trending across Twitter. Click to view dashboard

See who The is hiring next, click here to view